Consumers survey results of for 3 quarter of 2024 in category Gynecology, urology, nephrology / Medication for the treatment of menstrual cycle and PMS
The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year. |
|
I quarter (january—march) |
|
II quarter (april—june) |
|
III quarter (july—september) |
|
IV quarter (october—december) |
|
1. |
Гінекохеель (Heel)
|
50.00% |
5 |
|
1. |
Дисменорм (DHU) |
50.00% |
5 |
|
1. |
Мастодинон (Bionorica)
|
50.00% |
5 |
|
–. |
Tazalok (Pro-Pharma)
|
0.00% |
0 |
|
–. |
Мулімен (Heel)
|
0.00% |
0 |
|
–. |
Ременс (Perrigo)
|
0.00% |
0 |
|
–. |
Фемінал (Екомед) |
0.00% |
0 |
|
–. |
Циклодінон (Bionorica)
|
0.00% |
0 |
| |